L1 Capital’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-50,230
| Closed | -$11.6M | – | 14 |
|
|
2023
Q4 | $11.6M | Buy |
50,230
+1,761
| +4% | +$407K | 1.09% | 12 |
|
|
2023
Q3 | $7.08M | Buy |
48,469
+2,730
| +6% | +$399K | 0.6% | 12 |
|
|
2023
Q2 | $10.6M | Buy |
+45,739
| New | +$10.6M | 1.27% | 13 |
|
|
2023
Q1 | – | Sell |
-133,312
| Closed | -$38.7M | – | 13 |
|
|
2022
Q4 | $38.7M | Sell |
133,312
-27,851
| -17% | -$8.08M | 5.97% | 8 |
|
|
2022
Q3 | $10.5M | Sell |
161,163
-6,840
| -4% | -$445K | 2.05% | 10 |
|
|
2022
Q2 | $10.6M | Sell |
168,003
-47,313
| -22% | -$2.97M | 2.06% | 11 |
|
|
2022
Q1 | $15.1M | Buy |
215,316
+47,655
| +28% | +$3.34M | 1.83% | 10 |
|
|
2021
Q4 | $14.2M | Buy |
167,661
+2,801
| +2% | +$237K | 1.64% | 13 |
|
|
2021
Q3 | $13.2M | Hold |
164,860
| – | – | 1.64% | 13 |
|
|
2021
Q2 | $16.1M | Buy |
164,860
+52,256
| +46% | +$5.09M | 3.32% | 9 |
|
|
2021
Q1 | $13.2M | Sell |
112,604
-860
| -0.8% | -$101K | 3.31% | 9 |
|
|
2020
Q4 | $12.6M | Sell |
113,464
-1,197
| -1% | -$133K | 2.35% | 13 |
|
|
2020
Q3 | $13.6M | Sell |
114,661
-2,670
| -2% | -$317K | 4.37% | 7 |
|
|
2020
Q2 | $13.3M | Buy |
+117,331
| New | +$13.3M | 4.54% | 8 |
|